We are live on ! Find out more
PR

Payden & Rygel Portfolio holdings

AUM $1.3B
1-Year Est. Return 28.32%
This Fund
S&P 500
This Quarter Est. Return
+5.66%
1 Year Est. Return
+28.32%
3 Year Est. Return
+89.13%
5 Year Est. Return
+123.15%
10 Year Est. Return
+353.66%
AUM
$2.1B
AUM Growth
-$54.2M
Cap. Flow
-$174M
Cap. Flow %
-8.28%
Top 10 Hldgs %
21.2%
Holding
133
New
13
Increased
27
Reduced
66
Closed
7

Top Buys

Rank Stock Value
1
ABT icon
Abbott
ABT
+$30.5M
2
AEP icon
American Electric Power
AEP
+$28.5M
3
EPD icon
Enterprise Products Partners
EPD
+$27.3M
4
TSM icon
TSMC
TSM
+$23.9M
5
INTC icon
Intel
INTC
+$23.2M

Top Sells

Rank Stock Value
1
PNC icon
PNC Financial Services
PNC
+$38.1M
2
COP icon
ConocoPhillips
COP
+$37.9M
3
AVGO icon
Broadcom
AVGO
+$32.2M
4
KEY icon
KeyCorp
KEY
+$31.5M
5
MDT icon
Medtronic
MDT
+$28.2M

Sector Composition

Rank Sector Weight
1 Financials 19.32%
2 Healthcare 13.54%
3 Technology 11.41%
4 Industrials 10.64%
5 Energy 8.13%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
STZ icon
51
Constellation Brands
STZ
$22.2B
$22.6M 1.08%
96,700
+3,600
+4% +$845K
ARE icon
52
Alexandria Real Estate Equities
ARE
$8.88B
$22.5M 1.07%
123,700
+116,600
+1,642% +$20.9M
INTC icon
53
Intel
INTC
$466B
$22.1M 1.06%
+394,500
New +$23.2M
IBM icon
54
IBM
IBM
$202B
$22.1M 1.06%
158,009
+7,427
+5% +$1.02M
DUK icon
55
Duke Energy
DUK
$102B
$21.9M 1.04%
221,809
-163,427
-42% -$16.4M
DTE icon
56
DTE Energy
DTE
$31.1B
$21.9M 1.04%
198,223
-1,292
-0.6% -$151K
ABBV icon
57
AbbVie
ABBV
$458B
$21.6M 1.03%
191,800
-33,400
-15% -$3.76M
CFG icon
58
Citizens Financial Group
CFG
$30.4B
$21.6M 1.03%
469,800
-255,000
-35% -$12M
TJX icon
59
TJX Companies
TJX
$170B
$21.5M 1.03%
319,010
-117,636
-27% -$8.02M
GLW icon
60
Corning
GLW
$126B
$21.2M 1.01%
+517,400
New +$22.6M
WRK
61
DELISTED
WestRock Company
WRK
$20.9M 1%
393,600
+22,900
+6% +$1.28M
TROW icon
62
T. Rowe Price
TROW
$25B
$20.5M 0.98%
+103,800
New +$19.4M
CAG icon
63
Conagra Brands
CAG
$7.07B
$20.1M 0.96%
+553,500
New +$20.7M
TFC icon
64
Truist Financial
TFC
$63.2B
$19.6M 0.94%
353,600
-402,500
-53% -$23.6M
VTR icon
65
Ventas
VTR
$48.9B
$19.6M 0.93%
+343,200
New +$19.2M
PFE icon
66
Pfizer
PFE
$140B
$19.4M 0.93%
496,470
-3,100
-0.6% -$121K
UNH icon
67
UnitedHealth
UNH
$382B
$19.2M 0.91%
47,900
+2,000
+4% +$797K
LMT icon
68
Lockheed Martin
LMT
$134B
$19.1M 0.91%
50,400
+49,700
+7,100% +$19.1M
NEM icon
69
Newmont
NEM
$98.2B
$19M 0.91%
300,300
-28,000
-9% -$1.88M
FITB
70
Fifth Third Bancorp
FITB
$52B
$18.3M 0.87%
479,800
-479,500
-50% -$19.2M
HR icon
71
Healthcare Realty
HR
$7.42B
$17.6M 0.84%
660,700
-31,700
-5% -$897K
IVW icon
72
iShares S&P 500 Growth ETF
IVW
$72.5B
$11.7M 0.56%
160,212
-130,230
-45% -$9.01M
SCHM icon
73
Schwab US Mid-Cap ETF
SCHM
$14.6B
$10.2M 0.49%
392,142
-363,300
-48% -$9.38M
KBE icon
74
State Street SPDR S&P Bank ETF
KBE
$1.64B
$8.59M 0.41%
167,278
-8,580
-5% -$458K
HYG icon
75
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$16.3B
$3.74M 0.18%
42,500
-42,500
-50% -$3.71M

Similar funds

Payden & Rygel's Q2 2021 Portfolio in Review

As of Q2 2021, Payden & Rygel held 133 positions worth $2.1B, down 2.5% from $2.15B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Payden & Rygel withdrew a net $174M in Q2 2021, closing 7 positions and reducing 66 holdings. Its most notable exit was KeyCorp, an estimated $31.5M position sold in full.

By sector, the portfolio is most concentrated in Financials at 19% of assets, down from 25% a quarter earlier, followed by Healthcare and Technology.

Against the trend, Payden & Rygel opened a new position in Enterprise Products Partners worth $27.8M.

  • Payden & Rygel's largest Q2 2021 buy was Enterprise Products Partners: 1,152,300 shares worth $27.8M.
  • Payden & Rygel added most to Abbott in Q2 2021, an estimated $30.5M increase.
  • Payden & Rygel's biggest Q2 2021 reduction was PNC Financial Services, cutting an estimated $38.1M.
  • Payden & Rygel fully exited KeyCorp in Q2 2021, selling an estimated $31.5M.
  • Payden & Rygel's ten largest holdings make up 21% of its $2.1B portfolio in Q2 2021.
  • Payden & Rygel opened 13 new positions and closed 7 in Q2 2021.
  • Payden & Rygel's portfolio value fell 2.5% quarter-over-quarter to $2.1B.

Based on Payden & Rygel's 13F filing for Q2 2021, filed 6 Aug 2021.